Summary

Global Osteoarthritis Gene Therapy Market is valued approximately USD XX billion in 2020 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2021-2027. Osteoarthritis is a type of arthritis. arthritis affects millions of people worldwide. It occurs due to wear down of the protective cartilage that cushions the ends of the bones. The disorders most commonly affects joints in your hands, knees, hips, and spine. Rising prevalence of Osteoarthritis and increasing geriatric population are key driver for the growth of Osteoarthritis Gene Therapy. According to The Centers for Disease Control and Prevention’s estimates 1 in 4 (or 54.4 million) US adults have some form of arthritis, this figure is projected to reach 78 million by the year 2040 from 63 million in year 2020. As per Database company Statista’s estimates in 2019, the incidence of osteoarthritis of the knee in Europe was approximately 576 per 100,000 females and 419 per 100,000 males, making it the most common location of osteoarthritis. Furthermore, osteoarthritis of the hand occurred in 226 women per 100,000 and 134 men per 100,000. Also, with the surging healthcare infrastructure in emerging economies and rising technological advancements in field of Osteoarthritis Gene Therapy, the adoption & demand for Osteoarthritis Gene Therapy is likely to increase the market growth during the forecast period. However, high treatment cost of Osteoarthritis Gene Therapy impedes the growth of the market over the forecast period of 2021-2027.

The key regions considered for the global Osteoarthritis Gene Therapy market study includes Asia Pacific, North America, Europe, Latin America and Rest of the World. Europe is the leading/significant region across the world in terms of market share owing to rising prevalence of osteoarthritis cases in the region. Whereas North America is anticipated to exhibit highest growth rate / CAGR over the forecast period 2021-2027. Factors such as increasing government investments in various R&D activities in cell-based research would create lucrative growth prospects for the Osteoarthritis Gene Therapy market across Asia-Pacific region.

Major market player included in this report are:
Flexion
GeneQuine
Novartis
Smith & Nephew
Genascence
Kolon TissueGene
Sanofi
Paraxel
Medipost co ltd
Mundipharma.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Site of Injection:
Synovium
Cartilage
By Vectors:
Non-viral
Retrovirus
Lentivirus
Adenovirus
Adeno-associated virus (AAV)
HSV
By End Use Industries:
Hospitals and clinics
Orthopedic Centers
Assisted living Facilities
Nursing Homes
Ambulatory Surgical Centers
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027

Target Audience of the Global Osteoarthritis Gene Therapy Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

ページTOPに戻る

Table of Contents

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Osteoarthritis Gene Therapy Market, by Region, 2019-2027 (USD Billion)
1.2.2. Osteoarthritis Gene Therapy Market, by Site of Injection, 2019-2027 (USD Billion)
1.2.3. Osteoarthritis Gene Therapy Market, by Vectors, 2019-2027 (USD Billion)
1.2.4. Osteoarthritis Gene Therapy Market, by End Use Industries, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Osteoarthritis Gene Therapy Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Osteoarthritis Gene Therapy Market Dynamics
3.1. Osteoarthritis Gene Therapy Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Growing Prevalence of Osteoarthritis
3.1.1.2. increasing geriatric population
3.1.2. Market Challenges
3.1.2.1. High Treatment Cost.
3.1.3. Market Opportunities
3.1.3.1. Rising technological advancements in gene therapy
3.1.3.2. Surging Healthcare Infrastructure in emerging economies.
Chapter 4. Global Osteoarthritis Gene Therapy Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Osteoarthritis Gene Therapy Market, by Site of Injection
6.1. Market Snapshot
6.2. Global Osteoarthritis Gene Therapy Market by Site of Injection, Performance - Potential Analysis
6.3. Global Osteoarthritis Gene Therapy Market Estimates & Forecasts by Site of Injection 2018-2027 (USD Billion)
6.4. Osteoarthritis Gene Therapy Market, Sub Segment Analysis
6.4.1. Synovium
6.4.2. Cartilage
Chapter 7. Global Osteoarthritis Gene Therapy Market, by Vectors
7.1. Market Snapshot
7.2. Global Osteoarthritis Gene Therapy Market by Vectors, Performance - Potential Analysis
7.3. Global Osteoarthritis Gene Therapy Market Estimates & Forecasts by Vectors 2018-2027 (USD Billion)
7.4. Osteoarthritis Gene Therapy Market, Sub Segment Analysis
7.4.1. Non-viral
7.4.2. Retrovirus
7.4.3. Lentivirus
7.4.4. Adenovirus
7.4.5. Adeno-associated virus (AAV)
7.4.6. HSV


Chapter 8. Global Osteoarthritis Gene Therapy Market, by End Use Industries
8.1. Market Snapshot
8.2. Global Osteoarthritis Gene Therapy Market by End Use Industries, Performance - Potential Analysis
8.3. Global Osteoarthritis Gene Therapy Market Estimates & Forecasts by End Use Industries 2018-2027 (USD Billion)
8.4. Osteoarthritis Gene Therapy Market, Sub Segment Analysis
8.4.1. Hospitals and clinics
8.4.2. Orthopedic Centers
8.4.3. Assisted living Facilities
8.4.4. Nursing Homes
8.4.5. Ambulatory Surgical Centers
8.4.6. Others

Chapter 9. Global Osteoarthritis Gene Therapy Market, Regional Analysis
9.1. Osteoarthritis Gene Therapy Market, Regional Market Snapshot
9.2. North America Osteoarthritis Gene Therapy Market
9.2.1. U.S. Osteoarthritis Gene Therapy Market
9.2.1.1. Site of Injection breakdown estimates & forecasts, 2018-2027
9.2.1.2. Vectors breakdown estimates & forecasts, 2018-2027
9.2.1.3. End Use Industries breakdown estimates & forecasts, 2018-2027
9.2.2. Canada Osteoarthritis Gene Therapy Market
9.3. Europe Osteoarthritis Gene Therapy Market Snapshot
9.3.1. U.K. Osteoarthritis Gene Therapy Market
9.3.2. Germany Osteoarthritis Gene Therapy Market
9.3.3. France Osteoarthritis Gene Therapy Market
9.3.4. Spain Osteoarthritis Gene Therapy Market
9.3.5. Italy Osteoarthritis Gene Therapy Market
9.3.6. Rest of Europe Osteoarthritis Gene Therapy Market
9.4. Asia-Pacific Osteoarthritis Gene Therapy Market Snapshot
9.4.1. China Osteoarthritis Gene Therapy Market
9.4.2. India Osteoarthritis Gene Therapy Market
9.4.3. Japan Osteoarthritis Gene Therapy Market
9.4.4. Australia Osteoarthritis Gene Therapy Market
9.4.5. South Korea Osteoarthritis Gene Therapy Market
9.4.6. Rest of Asia Pacific Osteoarthritis Gene Therapy Market
9.5. Latin America Osteoarthritis Gene Therapy Market Snapshot
9.5.1. Brazil Osteoarthritis Gene Therapy Market
9.5.2. Mexico Osteoarthritis Gene Therapy Market
9.6. Rest of The World Osteoarthritis Gene Therapy Market

Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Flexion
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. GeneQuine
10.2.3. Novartis
10.2.4. Smith & Nephew
10.2.5. Genascence
10.2.6. Kolon TissueGene
10.2.7. Sanofi
10.2.8. Paraxel
10.2.9. Medipost co ltd
10.2.10. Mundipharma
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption